Throughout 2021, the medical and scientific communities have focused on managing the acute morbidity and mortality caused by the coronavirus disease 2019 (COVID-19) pandemic. With the approval of multiple vaccines, there is a light at the end of this dark tunnel and an opportunity to focus on the future, including managing the long-term sequelae in patients who have survived acute COVID-19. In this Perspectives article, we highlight what is known about the cardiovascular sequelae in survivors of COVID-19 and discuss important questions that need to be addressed in prospective studies to understand and mitigate these lasting cardiovascular consequences, including in post-acute COVID-19 syndrome. To provide the greatest benefit to these survivors, prospective studies should begin now, with resources made available to monitor and study this population in the coming years.

2021 年全年，医学界和科学界一直致力于管理 2019 年冠状病毒病 (COVID-19) 大流行引起的急性发病率和死亡率。随着多种疫苗的批准，这条黑暗隧道的尽头出现了曙光，也有机会关注未来，包括管理急性 COVID-19 幸存者的长期后遗症。在这篇展望文章中，我们重点介绍了有关 COVID-19 幸存者心血管后遗症的已知信息，并讨论了前瞻性研究中需要解决的重要问题，以了解和减轻这些持久的心血管后果，包括急性后 COVID-19 综合征。为了给这些幸存者提供最大的利益，前瞻性研究应该立即开始，并在未来几年提供资源来监测和研究这一人群。